Clinical Trial Update: Dapagliflozin After Transcatheter Aortic Valve Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dapagliflozin after transcatheter aortic valve implantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: Spanish Society of Cardiology | Conditions: Aortic Stenosis, Transcatether Aortic Valve Implantation | Phase 4 | Status: COMPLETED